ZEVIA PBC-A(NYSE:ZVIA) stock Fundamental Analysis

Fundamental Rating

Overall ZVIA gets a fundamental rating of 3 out of 10. We evaluated ZVIA against 31 industry peers in the Beverages industry. No worries on liquidiy or solvency for ZVIA as it has an excellent financial health rating, but there are worries on the profitability. ZVIA is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ZVIA has reported negative net income.

ZVIA had a negative operating cash flow in the past year.

ZVIA had negative earnings in each of the past 5 years.

In the past 5 years ZVIA always reported negative operating cash flow.

1.2 Ratios

ZVIA's Return On Assets of -29.50% is on the low side compared to the rest of the industry. ZVIA is outperformed by 89.29% of its industry peers.

The Return On Equity of ZVIA (-29.65%) is worse than 85.71% of its industry peers.

		Industry Rank	Sector Rank
ROA	-29.5%
ROE	-29.65%
ROIC	N/A

ROA(3y)-31.58%

ROA(5y)-25.34%

ROE(3y)-30.18%

ROE(5y)-27.5%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 44.27%, ZVIA perfoms like the industry average, outperforming 42.86% of the companies in the same industry.

ZVIA's Gross Margin has been stable in the last couple of years.

The Profit Margin and Operating Margin are not available for ZVIA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	44.27%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.06%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ZVIA does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ZVIA has been increased compared to 1 year ago.

There is no outstanding debt for ZVIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

ZVIA has an Altman-Z score of 421.28. This indicates that ZVIA is financially healthy and has little risk of bankruptcy at the moment.

ZVIA's Altman-Z score of 421.28 is amongst the best of the industry. ZVIA outperforms 100.00% of its industry peers.

There is no outstanding debt for ZVIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	421.28

ROIC/WACCN/A

WACC9.06%

2.3 Liquidity

A Current Ratio of 2.85 indicates that ZVIA has no problem at all paying its short term obligations.

With an excellent Current ratio value of 2.85, ZVIA belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.

ZVIA has a Quick Ratio of 1.96. This is a normal value and indicates that ZVIA is financially healthy and should not expect problems in meeting its short term obligations.

ZVIA's Quick ratio of 1.96 is amongst the best of the industry. ZVIA outperforms 85.71% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.85
Quick Ratio	1.96

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ZVIA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.63%.

ZVIA shows a decrease in Revenue. In the last year, the revenue decreased by -6.47%.

ZVIA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.80% yearly.

EPS 1Y (TTM)2.63%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%75%

Revenue 1Y (TTM)-6.47%

Revenue growth 3Y14.8%

Revenue growth 5YN/A

Sales Q2Q%-15.6%

3.2 Future

The Earnings Per Share is expected to grow by 19.93% on average over the next years. This is quite good.

ZVIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.43% yearly.

EPS Next Y23.91%

EPS Next 2Y20.4%

EPS Next 3Y19.93%

EPS Next 5YN/A

Revenue Next Year-6.61%

Revenue Next 2Y0.39%

Revenue Next 3Y3.43%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZVIA. In the last year negative earnings were reported.

Also next year ZVIA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ZVIA's earnings are expected to grow with 19.93% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y20.4%

EPS Next 3Y19.93%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ZVIA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ZEVIA PBC-A

NYSE:ZVIA (2/21/2025, 8:04:00 PM)

After market: 3.44 +0.06 (+1.78%)

3.38

-0.21 (-5.85%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryBeverages

Earnings (Last)11-06 2024-11-06/bmo

Earnings (Next)02-26 2025-02-26/bmo

Inst Owners50.41%

Inst Owner Change12.34%

Ins Owners4.23%

Ins Owner Change-0.22%

Market Cap246.77M

Analysts78.33

Price Target4.2 (24.26%)

Short Float %2.26%

Short Ratio1.33

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)31.57%

Min EPS beat(2)13.21%

Max EPS beat(2)49.94%

EPS beat(4)4

Avg EPS beat(4)19.49%

Min EPS beat(4)3.92%

Max EPS beat(4)49.94%

EPS beat(8)8

Avg EPS beat(8)29.61%

EPS beat(12)11

Avg EPS beat(12)24.46%

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)1

Avg Revenue beat(2)-3.63%

Min Revenue beat(2)-9.04%

Max Revenue beat(2)1.78%

Revenue beat(4)1

Avg Revenue beat(4)-2.9%

Min Revenue beat(4)-9.04%

Max Revenue beat(4)1.78%

Revenue beat(8)4

Avg Revenue beat(8)0.47%

Revenue beat(12)5

Avg Revenue beat(12)-0.62%

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)53.42%

PT rev (3m)124.96%

EPS NQ rev (1m)-16.67%

EPS NQ rev (3m)-16.67%

EPS NY rev (1m)-3.3%

EPS NY rev (3m)-1.62%

Revenue NQ rev (1m)0.66%

Revenue NQ rev (3m)0.66%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.23%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.61
P/FCF	N/A
P/OCF	N/A
P/B	3.4
P/tB	3.56
EV/EBITDA	N/A

EPS(TTM)-0.37

EYN/A

EPS(NY)-0.23

Fwd EYN/A

FCF(TTM)-0.08

FCFYN/A

OCF(TTM)-0.08

OCFYN/A

SpS2.1

BVpS0.99

TBVpS0.95

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-29.5%
ROE	-29.65%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	44.27%
FCFM	N/A

ROA(3y)-31.58%

ROA(5y)-25.34%

ROE(3y)-30.18%

ROE(5y)-27.5%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.06%

GM growth 5YN/A

F-Score5

Asset Turnover2.11

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	21.18%
Cap/Sales	0.2%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.85
Quick Ratio	1.96
Altman-Z	421.28

F-Score5

WACC9.06%

ROIC/WACCN/A

Cap/Depr(3y)202.14%

Cap/Depr(5y)150.35%

Cap/Sales(3y)1.61%

Cap/Sales(5y)1.22%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)2.63%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%75%

EPS Next Y23.91%

EPS Next 2Y20.4%

EPS Next 3Y19.93%

EPS Next 5YN/A

Revenue 1Y (TTM)-6.47%

Revenue growth 3Y14.8%

Revenue growth 5YN/A

Sales Q2Q%-15.6%

Revenue Next Year-6.61%

Revenue Next 2Y0.39%

Revenue Next 3Y3.43%

Revenue Next 5YN/A

EBIT growth 1Y4.42%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year46.95%

EBIT Next 3Y26.77%

EBIT Next 5YN/A

FCF growth 1Y78.08%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y76.6%

OCF growth 3YN/A

OCF growth 5YN/A

ZEVIA PBC-A (ZVIA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens